EFFECT OF ALKALINE CITRATE THERAPY ON CLEARANCE OF RESIDUAL RENAL STONE FRAGMENTS AFTER EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY IN STERILE CALCIUM AND INFECTION NEPHROLITHIASIS PATIENTS
E. Cicerello et al., EFFECT OF ALKALINE CITRATE THERAPY ON CLEARANCE OF RESIDUAL RENAL STONE FRAGMENTS AFTER EXTRACORPOREAL SHOCK-WAVE LITHOTRIPSY IN STERILE CALCIUM AND INFECTION NEPHROLITHIASIS PATIENTS, The Journal of urology, 151(1), 1994, pp. 5-9
The natural history of post-extracorporeal shock wave lithotripsy resi
dual stone fragments (clearance, growth and aggregation) is incomplete
ly known, even though they are believed to constitute a risk in terms
of new stone formation and persistent infection of the urinary tract.
We addressed this issue and the hypothesis that alkaline citrate thera
py improves residual stone fragment clearance in a 12-month followup s
tudy. There were 40 sterile calcium and 30 struvite stone patients wit
h residual fragments after extracorporeal shock wave lithotripsy (diam
eter less than 5 mm.) consecutively enrolled and randomly assigned to
a citrate therapy (6 to 8 gm. per day) or control (hygienic measures o
nly) group. Infection stone patients also received adequate antibiotic
therapy throughout the study. Among the patients in the untreated ste
rile group 21% and 32% were stone-free at 6 and 12 months, respectivel
y. In the infection group these figures were 27% and 40%, respectively
. Among the untreated sterile calcium stone patients in whom clearance
was not achieved a high percentage experienced residual fragment grow
th or reaggregation. Citrate therapy significantly improved the stone
clearance rate in the sterile (at 6 and 12 months 65% and 74% were sto
ne-free, respectively) and infection (71% and 86%, respectively) stone
patients, and prevented residual fragment growth or reaggregation in
subjects in whom clearance was not achieved. The data show that growth
and persistence are common in the natural history of residual stone f
ragments. Citrate ameliorated the outcome of these residual fragments
by reducing the growth or agglomeration, and by increasing the clearan
ce rate in calcium oxalate and in infection stone patients.